Who is the CEO of Suraksha Diagnostic Ltd?
- Answer Field
-
The CEO of Suraksha Diagnostic Ltd is Ms. Ritu Mittal.
BAJAJ BROKING
Overview of the Company: Core Business and Market Position
Suraksha Diagnostic Ltd, established in 2005, is a provider of pathology and radiology testing services across Eastern and Northeastern India. The company operates through a network of 44 diagnostic centers and 166 sample collection points, delivering services supported by advanced digital platforms like LIMS, PACS, and AI-driven pathology. These innovations streamline operations and enhance service quality.
With a strong market position in the fragmented diagnostic sector, Suraksha Diagnostic offers integrated services combining pathology, radiology, and medical consultancy under one roof. Its customer-centric approach has ensured high retention rates, especially in the underserved regions of Bihar, Assam, and West Bengal.
For more details, visit the Suraksha Diagnostic IPO page.
Details | Specifications |
IPO Date | November 29 – December 3, 2024 |
Price Band | ₹420 to ₹441 per share |
Total Issue Size | ₹846.25 crores |
Offer for Sale | 1.92 crore equity shares |
Face Value | ₹2 per share |
Listing At | NSE and BSE |
Purpose of the IPO
As mentioned in the company RHP, the Company will not receive any proceeds from the Offer for sale and all such proceeds will go to the Selling Shareholders, in proportion
to the Offered Shares sold by the respective Selling Shareholder as part of the Offer.
Event | Date |
IPO Open Date | November 29, 2024 |
IPO Close Date | December 3, 2024 |
Allotment Finalization | December 4, 2024 |
Refund Initiation | December 5, 2024 |
Listing Date | December 6, 2024 |
Price Band for the IPO
Minimum Lot Size and Application Details
Online Application Process
Key Financial Metrics
Recent Performance and Growth Prospects
Potential Risks of Investing in the IPO
Opportunities and Growth Potential
Metric | Value |
ROE | 14.09% |
ROCE | 21.46% |
Net Debt/Equity | 0.2 |
PAT Margin | 10.57% |
Role | Entity |
Registrar | KFin Technologies Ltd. |
Lead Managers | ICICI Securities, Nuvama Wealth Management, SBI Capital Markets |
Suraksha Diagnostic IPO offers investors an opportunity to participate in the growth of a leading diagnostic chain with strong market positioning and advanced digital capabilities. With its strategic expansion plans and robust technology, it promises long-term potential despite associated risks.
Interested in more opportunities? Check out our Upcoming IPO section for new listings and don’t forget to check your IPO allotment status for Suraksha Diagnostic IPO.
Disclaimer: Investments in the securities market are subject to market risk, read all related documents carefully before investing.
This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.
For All Disclaimers Click Here: https://bit.ly/3Tcsfuc
Share this article:
DAC Approves ₹21,772 Crore Defence Boost for Ships, Jets, and Tanks
04 Dec, 2024 | 2 Min. read
SECI Lifts Debarment on Reliance Power, Restores Bidding Rights
04 Dec, 2024 | 2 Min. read
RVNL Wins ₹186.77-Crore Project from East Central Railway
04 Dec, 2024 | 2 Min. read
PB Fintech Launches Wholly Owned Healthcare Services Subsidiary
04 Dec, 2024 | 2 Min. read
Commodities Market Today | Crude Oil and Precious Metals Prices See Significant Gains
04 Dec, 2024 | 1 Min. read
Share Market Today | Gift Nifty Hints At A Flat Opening For Indian Markets
04 Dec, 2024 | 4 Min. read
Gold Rate Today | Gold Rises 0.3% to $2,665.70, Silver Jumps 2.1%
04 Dec, 2024 | 2 Min. read
Risk-Reward Ratio Explained for Better Trading Decisions
04 Dec, 2024 | 5 Min. read
Momentum Indicators - Definition, Types, Benefits & Drawbacks
04 Dec, 2024 | 7 Min. read
Trailing Stop Loss: A Smart Strategy for Profit Protection
04 Dec, 2024 | 6 Min. read
Solar Industries Secures ₹2,039 Crore Export Order for Defence Products
03 Dec, 2024 | 2 Min. read
Protean eGov Technologies Secures ₹161 Crore CERSAI Project for CKYCRR 2.0
03 Dec, 2024 | 2 Min. read
RBI Launches ULI: Transforming Loan Access
August 27, 2024 | 4 Min. read
Textile Sector in India
September 20, 2024 | 5 Min. read
List of IPOs with DRHPs Filed
November 30, 2023 | 3 Min. read
Aditya Birla Group
September 28, 2023 | 10 Min. read
Bajaj Housing Finance Ltd IPO: Things Smart Investors Need to Know
September 05, 2024 | 4 Min. read
Budget Stock Ideas 2024-2025 | Stocks to Buy Today
July 24, 2024 | 4 Min. read
IPO Eligibility Criteria : Full Details
March 15, 2024 | 6 Min. read
What Is the Lock-In Period in IPOs?
October 18, 2023 | 6 Min. read
Godfrey Phillips Announces 2:1 Bonus Shares
September 16, 2024 | 7 Min. read
Jindal Group- A Comprehensive Analysis
September 27, 2024 | 7 Min. read
The CEO of Suraksha Diagnostic Ltd is Ms. Ritu Mittal.
The IPO will open for subscription on November 29, 2024.
Suraksha Diagnostic specializes in pathology and radiology services, supported by sustainable technology and customer-centric operations.
The diagnostic sector is witnessing robust growth, with increasing demand for organized diagnostic services in India.
Its integrated diagnostics model and advanced technology platforms ensure efficiency and scalability.
Log in to your Demat account, select the IPO, complete your application, and confirm payment via UPI.
While the IPO offers opportunities in preventive healthcare, risks include geographic concentration and high competition.
Dividend payment policies will be determined post-listing based on company profits.
No Result Found
Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading